Concentrated software holdings drove the Q1 decline, forcing a re-evaluation of the firm's growth thesis. Monitor upcoming filings for capital reallocations.
Alpha Score of 43 reflects weak overall profile with moderate momentum, weak value, weak quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.
The first quarter of 2026 brought a notable shift for Giverny Capital Asset Management, which reported a 7% decline in its portfolio performance. This downturn was driven primarily by heightened market volatility and a specific valuation correction within Constellation Software. As a firm known for concentrated positions, the performance of a single core holding exerts a disproportionate influence on the overall quarterly outcome.
The reliance on a narrow set of high-conviction holdings creates a distinct performance profile that can deviate sharply from broader indices during periods of sector-specific weakness. Constellation Software has long served as a primary engine for capital appreciation within the portfolio, but its recent price action highlights the sensitivity of growth-oriented software models to shifting market sentiment. When a primary holding experiences a valuation reset, the lack of diversification acts as a double-edged sword, amplifying the impact on the total fund value.
This event underscores the challenges of maintaining a high-conviction strategy in an environment where software valuations are increasingly scrutinized for their ability to sustain long-term compounding. Investors often look to stock market analysis to determine whether such pullbacks represent a fundamental change in the underlying business or a temporary misalignment of price and value. The current situation requires a re-evaluation of the firm's thesis regarding the scalability of its software-heavy portfolio.
Beyond the immediate impact of the Constellation Software decline, the broader portfolio faced headwinds from general market turbulence. The 7% drawdown serves as a reminder of the volatility inherent in active management strategies that prioritize long-term growth over hedging. The firm's ability to recover depends on its capacity to either double down on existing convictions or rotate capital into sectors that offer more stability during periods of market stress.
Agilent Technologies, Inc. remains a relevant component of the broader healthcare landscape, and its current standing provides a useful benchmark for sector-specific performance. According to AlphaScala data, Agilent Technologies, Inc. holds an Alpha Score of 55/100, categorized as Moderate. You can track further updates on the A stock page to see how similar industrial and healthcare-adjacent firms are navigating the current volatility.
The next concrete marker for Giverny Capital will be the subsequent quarterly filing, which will reveal whether the firm has adjusted its position sizes in response to the Q1 volatility. Investors should monitor the firm's capital allocation strategy, specifically looking for evidence of new entries or a reduction in exposure to software assets that have failed to meet growth expectations. The path forward hinges on whether the firm maintains its current concentration or shifts toward a more defensive posture to mitigate further downside risk in the coming quarters.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.